Changes in CGRP immunoreactivity at mammalian and amphibian motor nerve endings treated with botulinum toxin type-A.

Author： Meunier F.A.   Colasante C.   Molgo J.  

Publisher： Elsevier

ISSN： 0041-0101

Source： Toxicon, Vol.34, Iss.10, 1996-10, pp. : 1092-1092

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic botulinum type A toxin: factors affecting potency

By McLellan K.   Das R.E.G.   Ekong T.A.N.   Sesardic D.  

Toxicon, Vol. 34, Iss. 9, 1996-09 ,pp. : 975-985

Elsevier

Access to resources Recommend Favorite

The enterotoxin of clostridium perfringens type a binds to the presynaptic nerve endings in neuromuscular junctions of mouse phrenic nerve-diaphragm

By Senda T.   Sugimoto N.   Horiguchi Y.   Matsuda M.  

Toxicon, Vol. 33, Iss. 4, 1995-04 ,pp. : 499-506

Elsevier

Access to resources Recommend Favorite

Anomalous enhancement of botulinum toxin type A neurotoxicity in the presence of antitoxin

By Sheridan R.E.   Deshpande S.S.   Amersdorfer P.   Marks J.D.   Smith T.  

Toxicon, Vol. 39, Iss. 5, 2001-05 ,pp. : 651-657

Elsevier

Access to resources Recommend Favorite

Antagonism of botulinum toxin-induced muscle weakness by 3,4-diaminopyridine in rat phrenic nerve-hemidiaphragm preparations

By Adler M.   Scovill J.   Parker G.   Lebeda F.J.   Piotrowski J.   Deshpande S.S.  

Toxicon, Vol. 33, Iss. 4, 1995-04 ,pp. : 527-537

Elsevier

Access to resources Recommend Favorite

Stimulation of nerve endings via medical device

By  

MATEC Web of conference, Vol. 157, Iss. issue, 2018-03 ,pp. : 02049-02049

Edp Sciences

Access to resources Recommend Favorite